How an innovative Traumatic Brain Injury (TBI) company adapted its strategy after using the Walkthrough services of LOK Corporation.
The manufacturer of a new innovative non-invasive brain scanner that can assess and monitor the patient’s neurological status in real-time wanted to validate their strategy with two main goals:
Since the company was planning several studies, it was imperative to determine what NATO would think of this technology.
This new rapid device, which was comprehensive, non-invasive, and could detect, measure, and monitor in real-time, neurological disorders of the brain, could become a game changer in the patient management field — no better organization to confirm that than NATO and its partners.
When treating stroke and TBI, time to proper treatment is critical. Currently, there is no accurate, objective way to distinguish between TBI and important stroke subtypes. Delays can result in permanent disability or even death.
By simply doing a walkthrough of its strategic plan, the company was provided with judicious advice that considerably impacted its overall strategic approach. As a result the company realigned its go-to-market strategy. The 360 analytic view of LOK Corporation again clearly demonstrates our experience in the global market and the importance of our international network and collaboration with partners of choice, such as NATO.
It would be our pleasure to discuss this case report with you.
If you prefer to get feedback from the manufacturer on how our approach was beneficial to them, we would be happy to introduce and organize this discussion for you.
Sense Diagnostics has been working with Daniel Cloutier and LOK Corporation for over three years. During that time LOK has been extremely supportive of Sense Diagnostics as we have developed from an early-stage startup company to being on a fast track to FDA clearance of our first product.
Most importantly LOK has helped us gain financial support, clinical trial support in India as well as future manufacturing and distribution.
CEO Sense Diagnostics